Showing results (11-20 of 130) with videos related to
Sort By:
Pageof 13
Journal of Neural Transmission. Supplementum|January 1, 1994
Can our knowledge of monoamine oxidase (MAO) help in the design of better MAO inhibitors?P DostertPharmacological Research|January 7, 2000
Species-differences in disposition and reductive metabolism of methoxymorpholinodoxorubicin (PNU 152243), a new potential anticancer agentM Breda, M S Benedetti, R Battaglia, et al.British Journal of Clinical Pharmacology|December 1, 1996
Involvement of CYP2D6 but not CYP2C19 in nicergoline metabolism in humansY Böttiger, P Dostert, M S Benedetti, et al.Rapid Communications in Mass Spectrometry : RCM|February 5, 1998
Quantitative determination of cabergoline in human plasma using liquid chromatography combined with tandem mass spectrometryC Allievi, P DostertEnvironmental Health Perspectives|November 1, 1994
Induction and autoinduction properties of rifamycin derivatives: a review of animal and human studiesM Strolin Benedetti, P DostertJournal of Neural Transmission. Supplementum|January 1, 1987
Overview of the present state of MAO inhibitorsM Strolin Benedetti, P DostertNeuroscience Letters|April 25, 1994
Binding of 1,2(N)-dimethyl-6,7-dihydroxy-isoquinolinium ion to melanin: effects of ferrous and ferric ion on the bindingM Naoi, W Maruyama, P DostertJournal of Neurochemistry|June 1, 1995
Dopamine-derived 1-methyl-6,7-dihydroxyisoquinolines as hydroxyl radical promoters and scavengers in the rat brain: in vivo and in vitro studiesW Maruyama, P Dostert, M NaoiPageof 13